EU briefing warns AI health benefits need safeguards
EU health systems may benefit from AI in diagnostics, treatment, and disease surveillance, but privacy and misinformation risks remain.
A European Parliamentary Research Service briefing says AI could improve healthcare, disease prevention and well-being across the EU, but warns that its growing use in health advice, AI companions and tools used by children, young people and older adults requires strong safeguards and human oversight.
The briefing, focused on health and well-being in the age of AI, says AI is already supporting diagnostics, personalised treatment, health-risk forecasting, hospital management, pharmaceutical development and disease surveillance. It points to use cases in areas such as radiology, oncology, cardiology, rare diseases and cross-border health data exchange.
AI-powered health chatbots and virtual assistants can help people access health information, understand complex topics and prepare for medical consultations. However, the briefing warns that such tools may also create privacy risks, spread inaccurate or misleading information, and encourage users to delay or replace professional medical advice.
AI companions are presented as another area where benefits and risks coexist. They may support social interaction and alert caregivers when people are at risk of isolation, but cannot replace human relationships and may deepen loneliness or worsen mental health risks for vulnerable users.
For older adults, AI-enabled wearables, in-home sensors, assistive technologies and smart care platforms could support independent living and improve care. At the same time, the briefing warns of privacy and data security concerns, emotional dependency and the risk that technology could replace rather than complement personal interaction.
Young people and children face different risks as AI becomes part of daily life, learning, health advice and social interaction. The briefing highlights possible exposure to harmful content, cyberbullying, emotional dependency, privacy violations, reduced critical thinking, sleep disruption, sedentary behaviour and social withdrawal.
The research service says the EU AI Act, the General Data Protection Regulation, the European Health Data Space, and sector-specific rules on medical devices and diagnostics form part of the EU framework for managing these risks. It concludes that AI’s health benefits can be realised only if innovation is balanced with safeguards, digital skills and a commitment to keeping human care and social connection at the centre.
Why does it matter?
AI is becoming part of healthcare not only through clinical tools, but also through consumer-facing chatbots, companions, wearables and support systems used by vulnerable groups. That widens the policy challenge from medical safety to privacy, misinformation, emotional dependency, digital skills and the preservation of human care.
The briefing shows why health-related AI governance cannot rely only on innovation or efficiency gains. Trustworthy use will depend on safeguards that protect patients, children, older adults and other vulnerable users while ensuring AI supports, rather than replaces, professional care and social connection.
Would you like to learn more about AI, tech, and digital diplomacy? If so, ask our Diplo chatbot!